Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/600196 stock hub

SHA/600196 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600196is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

61B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600196

In the news

Latest news · SHA/600196

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E20.2

P25 17.1P50 24.2P75 37.8

Trailing P/E18.9

P25 23.5P50 41.3P75 83.2

ROE7

P25 -0.9P50 4.1P75 8.8

ROIC3

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600196 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

246

Groups with data

Currency

CNY

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	40,603
Employees Change	46%
Employees Change Percent	0.11
Enterprise value	CNY 99.8B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE000000X38
Last refreshed	2026-05-10
Market cap	CNY 61B
Price	CNY 24.82
Price currency	CNY
Rev Per Employee	1,042,152.39x
Sector	Healthcare
Sic	2834
Symbol	sha/600196
Website	https://www.fosunpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.69%
EV Earnings	28.71x
EV/EBIT	33.76x
EV/EBITDA	15.25x
EV/FCF	112.79x
EV/Sales	2.36x
FCF yield	1.45%
Forward P/E	20.18x
P/B ratio	0.96x
P/E ratio	18.95x
P/S ratio	1.44x
PE Ratio10 Y	24.88x
PE Ratio3 Y	22.9x
PE Ratio5 Y	24.09x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.99%
EBITDA Margin	14.6%
FCF margin	2.09%
Gross margin	50.31%
Gross Profit	CNY 21.3B
Gross Profit Growth	11.69%
Gross Profit Growth Q	11.25%
Gross Profit Growth3 Y	-0.71%
Gross Profit Growth5 Y	4.07%
Net Income	CNY 3.5B
Net Income Growth	18.86%
Net Income Growth Q	13.87%
Net Income Growth Quarters	7%
Net Income Growth Years	2%
Net Income Growth3 Y	-6.56%
Net Income Growth5 Y	-2.44%
Pretax Margin	12.1%
Profit Margin	8.22%
Profit Per Employee	CNY 85,625
Profitable Years	31
ROA	1.53
Roa5y	1.53
ROCE	3.42
ROE	7.04
Roe5y	7.3
ROIC	2.96
Roic5y	3.15

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	3.83%
Cagr15y	6.28%
Cagr1y	5.47%
Cagr20y	13.97%
Cagr3y	-6.89%
Cagr5y	-13.64%
Div CAGR10	1.34%
Div CAGR3	-17.02%
Div CAGR5	-3.88%
EPS Growth	19.43
EPS Growth Q	13.79
EPS Growth Quarters	7
EPS Growth Years	2
EPS Growth3 Y	-6.71
EPS Growth5 Y	-3.01
FCF Growth	159.5%
OCF Growth	14.97%
OCF Growth Q	8.8%
OCF Growth10 Y	11.28%
OCF Growth3 Y	7.8%
OCF Growth5 Y	12.58%
Revenue Growth	4.92x
Revenue Growth Q	6.93x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	-1.62x
Revenue Growth5 Y	5.43x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.35
Assets	CNY 123B
Cash	CNY 15.3B
Current Assets	CNY 34B
Current Liabilities	CNY 36.6B
Debt	CNY 39.5B
Debt EBITDA	CNY 6.04
Debt Equity	CNY 0.62
Debt FCF	CNY 44.67
Equity	CNY 63.7B
Interest Coverage	2.4
Liabilities	CNY 59.3B
Long Term Assets	CNY 89B
Long Term Liabilities	CNY 22.7B
Net Cash	CNY -24.2B
Net Cash By Market Cap	CNY -39.7
Net Debt EBITDA	CNY 3.92
Net Debt Equity	CNY 0.38
Net Debt FCF	CNY 27.39
Tangible Book Value	CNY 24.3B
Tangible Book Value Per Share	CNY 9.19
WACC	4.98

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.93
Inventory Turnover	3.27
Net Working Capital	CNY 6.1B
Quick ratio	0.71
Working Capital	CNY -2.6B
Working Capital Turnover	CNY -23.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.76%
Dividend Growth	18.52%
Dividend Growth Years	1%
Dividend per share	CNY 0.39
Dividend Years	25
Dividend Yield	1.57%
Ex Div Date	2025-08-04
Last Dividend	CNY 0.32
Payout Frequency	Annual
Payout Ratio	62.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	45.54%
1Y total return	5.47%
200-day SMA	27.49
3Y total return	-19.29%
50-day SMA	25.83
50-day SMA vs 200-day SMA	50under200
5Y total return	-51.96%
All Time High	91.69
All Time High Change	-72.93%
All Time High Date	2021-08-05
All Time Low	1.38
All Time Low Change	1,695.95%
All Time Low Date	1998-08-17
ATR	0.45
Beta	0.41
Beta1y	0.23
Beta2y	0.38
Ch YTD	-6.3
High	24.9
High52	33.1
High52 Date	2025-09-09
High52ch	-25.02%
Low	24.7
Low52	23.42
Low52 Date	2025-05-29
Low52ch	5.98%
Ma50ch	-3.9%
Price vs 200-day SMA	-9.73%
RSI	33.28
RSI Monthly	42.95
RSI Weekly	38.21
Sharpe ratio	0.16x
Sortino ratio	0.52
Total Return	2.33%
Tr YTD	-6.3
Tr15y	149.37%
Tr1m	-6.97%
Tr1w	0.2%
Tr3m	-6.97%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 3B
Operating Income Growth	11.95
Operating Income Growth Q	25.74
Operating Income Growth3 Y	-6.87
Operating Income Growth5 Y	0.51
Operating margin	6.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,635,575,347%
Net Borrowing	858,354,791
Shares Insiders	0.59%
Shares Institutions	15.85%
Shares Out	2,639,554,073
Shares Qo Q	0.84%
Shares Yo Y	-0.76%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 677.7M
Average Volume	18,908,947x
Bv Per Share	18.62
CAPEX	CNY -4.4B
Ch10y	29.68
Ch15y	108.7
Ch1m	-6.97
Ch1w	0.2
Ch1y	4.24
Ch20y	1,015
Ch3m	-6.97
Ch3y	-22.24
Ch5y	-54.58
Ch6m	-12.08
Change	0.36%
Change From Open	0.2
Close	24.73
Days Gap	0.16
Depreciation Amortization	3,221,104,294
Dollar Volume	483,379,676.2
Earnings Date	2026-04-28
EBIT	CNY 3B
EBITDA	CNY 6.2B
EPS	CNY 1.31
F Score	6
FCF	CNY 884.9M
FCF EV Yield	0.89x
FCF Per Share	CNY 0.34
Financing CF	-1,332,267,017
Fiscal Year End	December
Founded	1,994
Goodwill	10,796,766,098
Graham Number	23.42535
Graham Upside	-5.62
Income Tax	CNY 736M
Investing CF	-3,689,959,406
Is Primary Listing	1
Last Earnings Date	2026-04-28
Last Report Date	2026-03-31
Last Split Date	2010-07-26
Last Split Type	Forward
Lynch Fair Value	CNY 6.55
Lynch Upside	-73.61
Ma150	27.28
Ma150ch	-9%
Ma20	25.78
Ma20ch	-3.71%
Net CF	-60,375,265
Next Earnings Date	2026-08-26
Open	24.77
P FCF Ratio	68.99
P OCF Ratio	11.51
Payment Date	2025-08-04
Position In Range	60
Ppne	24,290,431,971
Price Date	2026-05-08
Price EBITDA	CNY 9.88
Ptbv Ratio	2.52
Relative Volume	1.04x
Revenue	42,314,513,427x
SBC By Revenue	0.49x
Share Based Comp	207,244,975
Tax By Revenue	1.74x
Tax Rate	14.37%
Tr20y	1,267.36%
Tr6m	-12.08%
Volume	19,475,410
Z Score	1.44

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600196 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.6%

$0.39 annual per share

Payout ratio

+62.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-3.9%

1 consecutive years of growth

Total shareholder yield

+2.3%

Next ex-dividend date: 2025-08-04

Performance

SHA/600196 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600196?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.9%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.8%

Negative means the company is buying back shares.

Technical

SHA/600196 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

33.3

Neutral momentum band

Price vs 200-day MA

-9.7%

50/200-day relationship not available

Beta (5Y)

0.41

Less volatile than the market

Sharpe ratio

0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600196

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600196 stock rating?

sha/600196 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600196 analysis?

The full report lives at /stocks/sha/600196/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600196?

The latest report frames sha/600196 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600196 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.